GlassScriptPhysician profile
Luis J Suau
NPI 1366418014
$2,762.47
in general payments reported to CMS, 2019-2025
18 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $402 · 2021: $655 · 2022: $461 · 2023: $424 · 2024: $305 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,110.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly Export S.A. Puerto Rico Branch | $702.94 | 2020-2025 | Verzenio, Jaypirca, Retevmo |
| E.R. Squibb & Sons, L.L.C. | $558.16 | 2020-2024 | Pomalyst |
| Janssen Pharmaceuticals, INC | $524.14 | 2019-2025 | Darzalex, Tecvayli |
| Astrazeneca Pharmaceuticals LP | $252.31 | 2023-2025 | Calquence, Enhertu, Tagrisso |
| Janssen Biotech, INC. | $160.95 | 2019-2020 | |
| Pbg Puerto Rico LLC | $78.69 | 2023-2024 | |
| Incyte Corporation | $71.17 | 2021-2023 | Jakafi |
| Merck Sharp & Dohme LLC | $71.15 | 2020-2021 | |
| Taiho Oncology, INC. | $63.38 | 2020-2022 | |
| Abbvie INC. | $57.48 | 2024-2025 | |
| Seagen INC. | $46.37 | 2020-2023 | Tukysa |
| Eisai INC. | $43.12 | 2019 | |
| Rigel Pharmaceuticals, INC. | $30.00 | 2023 | Rezlidhia, Tavalisse |
| Pfizer INC. | $27.74 | 2020-2021 | |
| Genzyme Corporation | $25.00 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Array Biopharma INC | $20.00 | 2022 | |
| Chiesi USA, INC. | $16.96 | 2021 | |
| Celgene Corporation | $12.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Suau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.